The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this investigation is to evaluate whether exenatide, a type 2 diabetes
medication, will improve the function of the innermost part of the arterial wall called the
endothelium after a fat-enriched meal and to determine how this occurs. The results of this
study will help to determine and understand a novel action of this group of diabetes
medications based on the action of naturally occuring gut substances called incretins. This
may have a significant impact on cardiovascular health in patients with early and
longstanding diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Carl T. Hayden VA Medical Center
Collaborators:
American Diabetes Association Amylin Pharmaceuticals, LLC.